Sulfamethoxazole

DESCRIPTION

A sulfonamide antibiotic; inhibits growth of E. coli (MIC = 10 μg/ml) and clinical MRSA isolates (MICs = 25-50 μg/ml); inhibits growth of MRSA in vivo in mice when administered in combination with trimethoprim (MIC = 0.8 μg/ml, ED50s = 6.4 and 9.6 mg/kg for two MRSA strains); acts by inhibiting DHPS; inhibits recombinant P. carinii DHPS (IC50 = 23 nM; Ki = 7.5 nM) and folate biosynthesis in situ by 48.6%; decreases recurrent infection in a mouse model of urinary tract infection with E. coli when administered in combination with trimethoprim

DETAILS

Inchi: InChI=1S/C10H11N3O3S/c1-7-6-10(12-16-7)13-17(14,15)9-4-2-8(11)3-5-9/h2-6H,11H2,1H3,(H,12,13)
Purity: ≥98%
Raptas: Product Type|Biochemicals|Antibiotics|Sulfonamides||Product Type|Biochemicals|Small Molecule Inhibitors|Nucleic Acid Turnover/Signaling||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Bacterial Diseases|MRSA
Smiles: NC1=CC=C(S(NC2=NOC(C)=C2)(=O)=O)C=C1
Inchikey: JLKIGFTWXXRPMT-UHFFFAOYSA-N
Cas Number: 723-46-6
Formulation: A crystalline solid
Storage Temp: -20
Shipping Temp: -20
Formula Markup: C10H11N3O3S
Formula Weight: 253.3
Shelf Life Days: 1460